Founded: : August 29, 2018
Products category: Diagnostic
Security and Exchange Commission (SEC) approval in the Philippines: June 29, 2018
First customer: Care and Cure Hub Inc.

The market approach used allowed for early and fast adoption of Clover Diagnostic Services, Inc.'s products with its customers without costing them any money upfront. As a result, several hundred patients monthly are being properly tested for the life threatening and altering disease of diabetes and COPD. The Clover Diagnostic Services, Inc. leadership team gathered the support of one of the largest HMOs in the country before launching their promotional efforts. Regular meetings with the CEO of this HMO, and President of a large chain of clinics, helped further the relationship and assurance of an aligned approach to saving lives and unnecessary healthcare expenses.

The HMO's senior leaders realize that saving money on costly complications associated with chronic diseases like diabetes and pulmonary disease is smart business for them, employers, and patients. Diagnosing and providing a prevention and wellness approach to managing these types of diseases is a key cornerstone to saving healthcare expenditures for all stakeholders. Employers recognize that it is too costly to have an unhealthy population of employees who often miss too many days of work and cost the organization directly and indirectly. The BPO industry has taken a very pro-active approach to addressing this issue by providing an avenue for their employees to have annual physical checkups and/or executive checkups.

As a result of the growth in ankle-brachial index (ABI) and spirometer (lung test) business, Clover Diagnostic Services, Inc. has added an audiometer to the portfolio. Opportunities became available to add therapeutic products to manage the chronic diseases of diabetes, and COPD, matching the strategic focus of the company. One key strategic focus is to provide solutions for identifying and managing at-risk patients for complications associated with this chronic diseases Clover Diagnostic Services, Inc. products diagnose, and/or manage.

Vision

Clover Diagnostic will become the leader in providing reliable and cost-effective diagnostic equipment for major chronic diseases (i.e. diabetes; COPD; etc..) to all of the major ASCs (ambulatory surgery centers) nationwide.

Mission

To align our strategies and tactics with HMOs, healthcare providers (clinics and doctors), and employers to identify patients at risk for costly complications associated with their chronic condition(s) and provide solutions to manage them effectively.

The market approach used allowed for early and fast adoption of Clover Diagnostic Services, Inc. products with its customers without costing them any money upfront. As a result, several hundred patients monthly are being properly tested for the life threatening and altering disease of hypertension, and/or arrhythmias. The Clover Diagnostic Services, Inc. leadership team gathered the support of one of the largest HMOs in the country before launching their promotional efforts. Regular meetings with the CEO of this HMO, and President of a large chain of clinics, helped further the relationship and assurance of an aligned approach to saving lives and unnecessary healthcare expenses.

The HMO's senior leaders realize that saving money on costly complications associated with chronic diseases like hypertension is smart business for them, employers, and patients. Diagnosing and providing a prevention and wellness approach to managing these types of diseases is a key cornerstone to saving healthcare expenditures for all stakeholders. Employers recognize that it is too costly to have an unhealthy population of employees who often miss too many days of work, and cost the organization directly and indirectly. The BPO industry has taken a very pro-active approach to addressing this issue by providing an avenue for their employees to have annual and/or executive checkups annually.

As a result of the growth in 24-hour ABPM and holter business, Clover Diagnostic Services, Inc. has added ankle-bracial index(ABI) to the portfolio, and spirometers (lung test). Opportunities became available to add therapeutic products to manage the chronic diseases of hypertension, diabetes, and COP, matching the strategic focus of the company. One key strategic focus is to provide solutions for identifying and managing at-risk patients for complications associated with the 3 chronic diseases Clover Diagnostic Services, Inc. products diagnose, and/or manage.